132 related articles for article (PubMed ID: 8398843)
1. Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH).
Phillips JK; Majumdar G; Hunt BJ; Savidge GF
Br J Haematol; 1993 Jun; 84(2):349-50. PubMed ID: 8398843
[TBL] [Abstract][Full Text] [Related]
2. Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Blickstein D; Hod M; Bar J
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):765-8. PubMed ID: 14614358
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
Eriksson BI; Söderberg K; Widlund L; Wandeli B; Tengborn L; Risberg B
Thromb Haemost; 1995 Mar; 73(3):398-401. PubMed ID: 7667822
[TBL] [Abstract][Full Text] [Related]
4. Deep vein thrombosis in pregnancy and heparin hypersensitivity.
Ojukwu C; Jenkinson SD; Obeid D
Br J Obstet Gynaecol; 1996 Sep; 103(9):934-6. PubMed ID: 8813320
[No Abstract] [Full Text] [Related]
5. Drug eruption due to low molecular weight heparin.
Chung TS; Kim SC
Acta Derm Venereol; 2000 May; 80(3):211. PubMed ID: 10954216
[No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
9. Dalteparin: new indication. Prophylaxis in medical patients: no advance.
Prescrire Int; 2005 Feb; 14(75):14-5. PubMed ID: 15751168
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
Polkinghorne KR; McMahon LP; Becker GJ
Am J Kidney Dis; 2002 Nov; 40(5):990-5. PubMed ID: 12407644
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of low molecular weight heparin.
Fletcher JP; Ao PY; Hawthorne WJ
ANZ J Surg; 2004 Sep; 74(9):793-6. PubMed ID: 15379813
[TBL] [Abstract][Full Text] [Related]
14. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity.
Carlson MK; Gleason PP; Sen S
Pharmacotherapy; 2001 Jan; 21(1):108-13. PubMed ID: 11191729
[TBL] [Abstract][Full Text] [Related]
15. [The use of low-molecular heparin for anticoagulation in pregnancy].
Kelbel C; Hafner G; Schinzel H; Prellwitz W; Weilemann LS
Dtsch Med Wochenschr; 1994 Nov; 119(44):1497-500. PubMed ID: 7956777
[TBL] [Abstract][Full Text] [Related]
16. Immediate type hypersensitivity after injection of nadroparin (Fraxiparin).
Bekkenk MW; van Zuuren EJ
Thromb Haemost; 2005 Sep; 94(3):673-4. PubMed ID: 16268488
[No Abstract] [Full Text] [Related]
17. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
18. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
[TBL] [Abstract][Full Text] [Related]
19. Rare presentation of enoxaparin-induced skin necrosis in a postoperative patient.
Byrne EM; Khattab A; Chen F; Bhagavatula R
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35418382
[TBL] [Abstract][Full Text] [Related]
20. Safety of low-molecular-weight heparin in pregnancy: a systematic review.
Sanson BJ; Lensing AW; Prins MH; Ginsberg JS; Barkagan ZS; Lavenne-Pardonge E; Brenner B; Dulitzky M; Nielsen JD; Boda Z; Turi S; Mac Gillavry MR; Hamulyák K; Theunissen IM; Hunt BJ; Büller HR
Thromb Haemost; 1999 May; 81(5):668-72. PubMed ID: 10365733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
